Page last updated: 2024-08-18

2-naphthol and Bowel Diseases, Inflammatory

2-naphthol has been researched along with Bowel Diseases, Inflammatory in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beibel, M; Berry, D; Bhuju, S; Dammann, K; Ebner, F; Evstatiev, R; Gasche, C; Khare, V; Kovarik, P; Kuzyk, O; Lang, M; Loy, A; Meisner-Kober, N; Mesteri, I; Passecker, K; Roma, G; Sedlyarov, V1
Edsall, RJ; Harris, HA; Henderson, RA; Keith, JC; Manas, ES; Mewshaw, RE; Xu, ZB; Yang, C1

Other Studies

2 other study(ies) available for 2-naphthol and Bowel Diseases, Inflammatory

ArticleYear
HuR Small-Molecule Inhibitor Elicits Differential Effects in Adenomatosis Polyposis and Colorectal Carcinogenesis.
    Cancer research, 2017, 05-01, Volume: 77, Issue:9

    Topics: Adenomatous Polyposis Coli; Animals; Apoptosis; Carcinogenesis; Cell Proliferation; Chemokine CCL11; Colorectal Neoplasms; ELAV-Like Protein 1; Feces; Furans; Gastrointestinal Microbiome; HCT116 Cells; Humans; Inflammatory Bowel Diseases; Interleukin-18; Mice; Naphthols; RAW 264.7 Cells

2017
ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity.
    Journal of medicinal chemistry, 2005, Jun-16, Volume: 48, Issue:12

    Topics: Animals; Animals, Genetically Modified; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Binding Sites; Cell Line, Tumor; Crystallography, X-Ray; Estrogen Receptor beta; Female; Genistein; Humans; Inflammatory Bowel Diseases; Ligands; Male; Models, Molecular; Molecular Conformation; Molecular Mimicry; Molecular Structure; Naphthalenes; Naphthols; Organ Size; Rats; Rats, Inbred Lew; Structure-Activity Relationship; Transcription, Genetic; Uterus

2005